Masimo revenue to fall -27% YOY in 2025 as non-healthcare unit exits books

Masimo (NASDAQ: MASI), the US-based medical technology company, is poised for a -27% year-on-year revenue decline in 2025 following its decision to divest Sound United, its non-healthcare audio division. The unit, which makes high-end home entertainment systems, was acquired in 2022 and accounted for roughly a third of Masimo’s revenue in 2024.

The sale marks a strategic shift back to Masimo’s core healthcare operations, which are forecast to grow +9% in 2025. Weaker consumer demand and elevated interest rates had weighed on Sound United’s performance, prompting the company to classify the division as “held for sale” and reallocate it to discontinued operations.

Analysts expect revenue growth to resume from 2026, with total sales forecast to rise +8% to $1.6 billion, driven by steady expansion in Masimo’s healthcare division, which includes patient monitoring and hospital automation technologies.